[Drug targeting in antineoplastic chemotherapy: antigens and receptors in the tumor cell surface as an attack point for selective chemotherapy].
Kratz
F
F
Anorganisch-Chemisches Institut, Universität, Heidelberg.
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D011956:Receptors, Cell Surface / Q000187:drug effects*
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000970:Antineoplastic Agents; D011956:Receptors, Cell Surface
Drug Targeting in der antitumoralen Chemotherapie: Antigene und Rezeptoren auf der Tumorzelloberfläche als Angriffspunkte einer selektiven Chemotherapie.